转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

doi:10.16352/j.issn.1001-6325.2024.07.1023

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (7): 1023-1028.doi: 10.16352/j.issn.1001-6325.2024.07.1023

转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

王泽颖, 刘治, 邰玉, 杨忠彬, 苏燕^*

包头医学院生物化学与分子生物学教研室,内蒙古包头 014010

收稿日期:2023-09-15 修回日期:2024-03-19 出版日期:2024-07-05 发布日期:2024-06-26
通讯作者: ^*synmg@126.com
基金资助:
国家自然科学基金(81860029);内蒙古自然科学基金(2020MS08008);草原英才滚动计划(2021);2021年卫生健康科技计划(202201394)

Progress on the role of transketolase in occurrence and treatment of diabetes and its complications

WANG Zeying, LIU Zhi, TAI Yu, YANG Zhongbin, SU Yan^*

Department of Biochemistry and Molecular Biology, Baotou Medical College, Baotou 014010, China

Received:2023-09-15 Revised:2024-03-19 Online:2024-07-05 Published:2024-06-26
Contact: ^*synmg@126.com

摘要/Abstract

摘要： 转酮醇酶(TKT)是催化磷酸戊糖途径(PPP)非氧化阶段基团转移反应的重要酶,参与机体各类能源物质,如葡萄糖、核糖、核苷酸以及脂质的代谢。TKT可以通过抑制高糖环境下蛋白质和脂质非酶糖基化(NEG)产生的晚期糖基化终末产物(AGEs),减少氧化应激、炎性反应、动脉粥样硬化、内皮功能障碍以及Tau蛋白磷酸化等,进而改善血糖、糖耐量和β细胞功能,达到预防和治疗糖尿病及其并发症的作用。

关键词: 转酮醇酶, 糖尿病, 代谢, 磷酸戊糖途径

Abstract: Transketolase (TKT) is an important enzyme that catalyzes the non-oxidative phase group transfer reaction of pentose phosphate pathway (PPP), and is involved in the metabolism of various energy substances in the body, such as glucose, ribose, nucleotides and lipids. TKT can reduce oxidative stress, inflammation, atherosclerosis, endothelial dysfunction and Tau protein phosphorylation by inhibiting advanced glycated end-produces(AGEs) produced by non-enzymatic glycosylation (NEG) of proteins and lipids in a high-glucose environment improving blood glucose, glucose tolerance and β cell function so to prevent and treat diabetes and its complications. This article reviews research progress on the mechanism of TKT in the treatment of diabetes mellitus and its complications.

Key words: transketolase, diabetes, metabolism, pentose phosphate pathway

中图分类号:

王泽颖, 刘治, 邰玉, 杨忠彬, 苏燕. 转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展[J]. 基础医学与临床, 2024, 44(7): 1023-1028.

WANG Zeying, LIU Zhi, TAI Yu, YANG Zhongbin, SU Yan. Progress on the role of transketolase in occurrence and treatment of diabetes and its complications[J]. Basic & Clinical Medicine, 2024, 44(7): 1023-1028.

参考文献

[1]Kochetov GA, Solovjeva ON. Structure and functioning mechanism of transketolase[J].Biochim Biophys Acta,2014, 1844:1608-1618.
[2]Deshpande GP, Patterton HG, Faadiel Essop M. The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases[J], BMC Struct Biol, 2019, 19:10.1186/s12900-018-0099-y.
[3]Schulz MC, Dubourg V, Nolze A, et al.TKT Acidosis activates the Nrf2 pathway in renal proximal tubule-derived cells through a crosstalk with renal fibroblasts[J]. Antioxidants (Basel), 2023, 12.doi:10.3390/antiox12020412.
[4]Wang Z, Qiu Z, Hua S, et al. Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis[J]. Basic Res Cardiol, 2022, 117:18. doi: 10.1007/s00395-022-00925-8.
[5]Baptista I, Karakitsou E, Cazier JB, et al. TKTL1 knockdown impairs hypoxia-induced glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase overexpression[J]. Int J Mol Sci, 2022, 23. doi:10.3390/ijms23073574.
[6]Beltramo E, Mazzeo A, Porta M.Thiamine and diabetes: back to the future?[J].Acta Diabetologica, 2021.doi:10.1007/s00592-021-01752-4.
[7]Sambon M, Wins P, Bettendorff L. Neuroprotective effects of thiamine and precursors with higher bioavailability: focus on benfotiamine and dibenzoylthiamine[J]. Int J Mol Sci, 2021, 22. doi:10.3390/IJMS22115418.
[8]Cakir I, Lining Pan P, Hadley CK, et al. Sulforaphane reduces obesity by reversing leptin resistance[J]. Elife 2022, 11.doi:10.7554/eLife.67368.
[9]Xue M, Qian Q, Adaikalakoteswari A,et al.Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease[J].Diabetes, 2008, 57:2809-2817.doi:10.2337/db06-1003.
[10]Gillis SP, Yao H, Rizal S,et al.Loss of the transcriptional repressor Rev-erbα upregulates metabolism and prolifera-tion in cultured mouse embryonic fibroblasts[J].Sci Rep, 2021, 11:12356.doi:10.1038/s41598-021-91516-5.
[11]Ziegler D, Reiners K, Strom A,et al. Association between diabetes and thiamine status-A systematic review and meta-analysis[J].Metabolism, 2023: 155565. doi:10.1016/j.metabol.2023.155565.
[12]曹潇, 于乐祥, 魏艳, 等.雌性GK糖尿病大鼠的核糖,AGEs和转酮酶变化[J]. 生物化学与生物物理进展, 2022, 49:949-952.
[13]Dasgupta A, Bakshi A, Chowdhury N,et al.A control theoretic three timescale model for analyzing energy management in mammalian cancer cells[J].Comput Struct Biotechnol J, 2020, 2020,19:477-508.doi:10.1016/j.csbj.2020.12.019.
[14]Tian N, Liu Q, Li Y,et al.Transketolase deficiency in adipose tissues protects mice from diet-induced obesity by promoting lipolysis[J].Diabetes, 2020, 69:db191087.doi:10.2337/db19-1087.
[15]Ji Y, Liu W, Zhu Y, et al. Loss of transketolase promotes the anti-diabetic role of brown adipose tissues[J]. J Endocrinol, 2023, 256. doi:10.1530/JOE-22-0047.
[16]Sun H, Saeedi P, Karuranga S,et al.IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract, 2022, 183:109119.doi:10.1016/j.diabres.2021.109119.
[17]Stirban A, Negrean M, Stratmann B,et al.Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes[J].Diabetes Care, 2006, 29:2064-2071.doi:10.2337/dc06-0531.
[18]Babaei-Jadidi R, Karachalias N, Ahmed N,et al.Preven-tion of incipient diabetic nephropathy by high-dose thiamine and benfotiamine[J].Diabetes, 2002, 52:2110-2120.doi:10.2337/diabetes.52.8.2110.
[19]Ziegler D, Tesfaye S, Spallone V,et al.Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations[J].Diabetes Res Clin Practice, 2021:109063.doi:10.1016/j.diabres.2021.109063.
[20]Jones KS, Parkington DA, Cox LJ,et al.Erythrocyte transketolase activity coefficient (ETKAC) assay protocol for the assessment of thiamine status[J].Ann N Y Acad Sci,2021,1498:77-84.doi:10.1111/nyas.14547.
[21]Spallon V.Might genetics play a role in understanding and treating diabetic polyneuropathy?[J].Diabetes Metab Res Rev, 2017, 33.doi:10.1002/dmrr.2882.
[22]Chen Y, Zhang T, Zeng S, et al. Transketolase in human Muller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways[J]. Redox Biol, 2022, 54:102379.doi: 10.1016/j.redox.2022.102379.
[23]Tian N, Hu L, Lu Y, et al. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis[J].Cell Death Dis, 2021, 12:853.doi: 10.1038/s41419-021-04142-4.
[24]张雅慧,白琼. 低氧诱导因子-1α在糖尿病肾病中作用机制的研究进展[J]. 基础医学与临床,2024,44:114-118.
[25]孙明玥,李旭妍,萨如拉,等. 2型糖尿病患者红细胞变形能力改变与RBC能量代谢相关[J]. 基础医学与临床,2021,41:245-249.

转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

Progress on the role of transketolase in occurrence and treatment of diabetes and its complications

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何光亮, 王涛, 刘磊, 周建, 叶敏. 新生儿高氧相关肺疾病的代谢异常[J]. 基础医学与临床, 2024, 44(7): 1034-1038.
[2]	齐梦亚, 李玉秀, 余洁, 张化冰, 许翎岭, 李伟, 平凡. 新确诊糖尿病患者增加运动与降低胰岛素抵抗和心血管危险因素相关[J]. 基础医学与临床, 2024, 44(7): 984-988.
[3]	余志鑫, 邙新雨, 邹定峰, 缪时英, 宋伟, 李凯. 腹腔注射白消安对精原干细胞代谢特征的影响[J]. 基础医学与临床, 2024, 44(6): 793-799.
[4]	段然, 李青原, 冯同. 代谢重编程在特发性肺纤维化发病中的作用[J]. 基础医学与临床, 2024, 44(6): 882-886.
[5]	刘潇, 王曌慧, 魏心怡, 周玥, 赵丽, 王玥, 李俊发. 糖尿病合并TREM2突变相关认知功能障碍的生物信息学分析[J]. 基础医学与临床, 2024, 44(5): 630-636.
[6]	丁宝锋, 王小爽, 王芳, 余佳. 肥胖模型小鼠肝脏的病理变化及代谢组分析[J]. 基础医学与临床, 2024, 44(5): 699-704.
[7]	王瑞, 柒铭铭, 杨微涛, 黄健, 肖锦艳, 李一春, 王永红, 刘燕萍. 综合营养管理对妊娠期糖尿病患者的血糖及妊娠结局的影响[J]. 基础医学与临床, 2024, 44(4): 434-439.
[8]	郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.
[9]	魏斌, 段红杰, 柴家科. 代谢组学在重伤诊治中的研究进展[J]. 基础医学与临床, 2024, 44(4): 562-567.
[10]	白璐, 王佳新, 王雪, 曾巍, 宋美月, 张田甜, 王婧. 脂肪酸代谢重编程在肺纤维化中的研究进展[J]. 基础医学与临床, 2024, 44(4): 548-552.
[11]	陈雪, 罗添, 魏超君. 溶血磷脂酰胆碱酰基转移酶1在肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(2): 256-259.
[12]	秦小英, 刘慧, 韩冲芳, 贺建东. 改善昼夜节律紊乱减轻糖尿病大鼠心肌缺血/再灌注损伤[J]. 基础医学与临床, 2024, 44(2): 231-234.
[13]	陈恩惠, 杨佳卉, 赵微, 解相宏, 郭艳芳, 刘晓军, 闫莉. Nutlin-3a通过抑制CIDEC的表达调控小鼠脂肪功能[J]. 基础医学与临床, 2024, 44(2): 154-158.
[14]	张雅慧, 白琼. 低氧诱导因子-1α在糖尿病肾病中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(1): 114-118.
[15]	吴国嘏, 翟书杰, 孙笑, 黄怡然, 李咏梅, 孙丽. 羟酰辅酶A脱氢酶在癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(1): 119-123.